San Francisco-based MiLaboratories has raised $10 million in Series A funding to enhance its computational biology platform designed for genomic research. The platform simplifies the analysis of vast genomic data, integrating features like data visualization and generative AI. MiLaboratories aims to empower bioinformaticians, allowing them to focus on complex tasks rather than routine data processing. Currently in use by around 300 labs, the platform also facilitates third-party app development. With major pharma companies as clients, the startup is poised to make significant advancements in vaccine and cancer treatment research.